Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Enhertu
Pharma
ESMO: Enhertu wields 2-fisted power in early breast cancer
The AstraZeneca and Daiichi star ADC showed strong efficacy separately as neoadjuvant and adjuvant therapy in HER2-positive early breast cancer.
Angus Liuu
Oct 18, 2025 10:30am
Novo-KBP, Takeda, Enhertu—Fierce Pharma Asia
Oct 2, 2025 4:02pm
AZ, Daiichi's Enhertu notches another win in early breast cancer
Sep 29, 2025 12:00pm
Glenmark, Hengrui ink $1.1B deal for HER2 ADC
Sep 24, 2025 10:16am
AZ, Genentech, Merck top oncology HCP promotions: report
Aug 14, 2025 11:52am
Soriot plots move of AZ stock listing to US: The Times
Jul 2, 2025 11:10am
